Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Change in Cash: 2018-2024

Historic Change in Cash for Silence Therapeutics (SLN) over the last 7 years, with Dec 2024 value amounting to $52.5 million.

  • Silence Therapeutics' Change in Cash rose 172.43% to $40.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 108.98%. This contributed to the annual value of $52.5 million for FY2024, which is 2866.70% up from last year.
  • As of FY2024, Silence Therapeutics' Change in Cash stood at $52.5 million, which was up 2,866.70% from $1.8 million recorded in FY2023.
  • In the past 5 years, Silence Therapeutics' Change in Cash registered a high of $63.6 million during FY2021, and its lowest value of -$25.0 million during FY2022.
  • In the last 3 years, Silence Therapeutics' Change in Cash had a median value of $1.8 million in 2023 and averaged $9.8 million.
  • Per our database at Business Quant, Silence Therapeutics' Change in Cash slumped by 139.27% in 2022 and then spiked by 2,866.70% in 2024.
  • Yearly analysis of 5 years shows Silence Therapeutics' Change in Cash stood at $18.3 million in 2020, then skyrocketed by 246.83% to $63.6 million in 2021, then plummeted by 139.27% to -$25.0 million in 2022, then soared by 107.09% to $1.8 million in 2023, then skyrocketed by 2,866.70% to $52.5 million in 2024.